Colinna1
Those announcements generally don't mention scaleback conditions. You never know what you're goning to get (apologies to Forest Gump) until they new shares are issued.
PeaceAKKI
There was a discussion of the cash burn comparison with DNDN some time ago. Apparently DNDN took several wrong paths along the way through the clinical trials and FDA approvals process and burned a lot of cash as a result. MR was pretty confident when I asked him about this that they had learned much from DNDN's experience and that PRR's path was much smoother as a result.
ann - spp completed , page-21
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.003(0.78%) |
Mkt cap ! $469.0M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 31.8¢ | $408.3K | 1.261M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 414040 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 241143 | 46 |
View Market Depth
| Last trade - 14.12pm 14/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |